Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Abbott Laboratories 12.593, Becton Dickinson 4.983.
Abbott Laboratories vs Becton Dickinson Net Worth and Market Cap
Abbott Laboratories (ABT) and Becton Dickinson (BDX) are peers in Healthcare. Abbott Laboratories reported revenue of $12.6B as of Q2 2026, compared with $5.0B for Becton Dickinson. Abbott Laboratories leads on revenue.
Abbott Laboratories's gross margin is 58.0% versus 46.5% for Becton Dickinson. Abbott Laboratories's net margin is 7.4% versus 7.6% for Becton Dickinson.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Abbott Laboratories, Becton Dickinson.| Metric | Abbott Laboratories | Becton Dickinson |
|---|---|---|
| Market Cap | - | - |
| Revenue | $12.59B | $4.98B |
| Cost of Revenue | $5.29B | $2.67B |
| Gross Profit | $7.30B | $2.31B |
| Operating Income | $1.78B | $663.00M |
| Net Income | $928.00M | $377.00M |
| R&D Expense | $882.00M | $258.00M |
| Earnings Per Share | $0.53 | $1.37 |
| Gross Margin | 58.0% | 46.5% |
| Operating Margin | 14.2% | 13.3% |
| Net Profit Margin | 7.4% | 7.6% |
| Free Cash Flow | $2.89B | $509.00M |
| Cumulative Free Cash Flow | $142.48B | $39.60B |
| Operating Cash Flow | $2.49B | $652.00M |
| Cash & Equivalents | $5.10B | $708.00M |